216 related articles for article (PubMed ID: 22517489)
1. Impact of progression of Parkinson's disease on drooling in various ethnic groups.
Rana AQ; Yousuf MS; Awan N; Fattah A
Eur Neurol; 2012; 67(5):312-4. PubMed ID: 22517489
[TBL] [Abstract][Full Text] [Related]
2. Impact of cognitive dysfunction on drooling in Parkinson's disease.
Rana AQ; Khondker S; Kabir A; Owalia A; Khondker S; Emre M
Eur Neurol; 2013; 70(1-2):42-5. PubMed ID: 23711510
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of diurnal drooling in Parkinson's disease.
Kalf JG; Munneke M; van den Engel-Hoek L; de Swart BJ; Borm GF; Bloem BR; Zwarts MJ
Mov Disord; 2011 Aug; 26(9):1670-6. PubMed ID: 21484876
[TBL] [Abstract][Full Text] [Related]
4. Is drooling secondary to a swallowing disorder in patients with Parkinson's disease?
Nóbrega AC; Rodrigues B; Torres AC; Scarpel RD; Neves CA; Melo A
Parkinsonism Relat Disord; 2008; 14(3):243-5. PubMed ID: 17892967
[TBL] [Abstract][Full Text] [Related]
5. Impact of ethnicity on non-motor symptoms of Parkinson's disease.
Rana AQ; Athar A; Owlia A; Siddiqui I; Awan N; Fattah A; Rana MA
J Parkinsons Dis; 2012; 2(4):281-5. PubMed ID: 23938258
[TBL] [Abstract][Full Text] [Related]
6. The impact of and the factors associated with drooling in Parkinson's disease.
Leibner J; Ramjit A; Sedig L; Dai Y; Wu SS; Jacobson C; Okun MS; Rodriguez RL; Malaty IA; Fernandez HH
Parkinsonism Relat Disord; 2010 Aug; 16(7):475-7. PubMed ID: 20064737
[TBL] [Abstract][Full Text] [Related]
7. Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease.
Perez Lloret S; Pirán Arce G; Rossi M; Caivano Nemet ML; Salsamendi P; Merello M
Mov Disord; 2007 Jan; 22(1):107-11. PubMed ID: 17089393
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology underlying drooling in Parkinson's disease: oropharyngeal bradykinesia.
Karakoc M; Yon MI; Cakmakli GY; Ulusoy EK; Gulunay A; Oztekin N; Ak F
Neurol Sci; 2016 Dec; 37(12):1987-1991. PubMed ID: 27613712
[TBL] [Abstract][Full Text] [Related]
9. Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease?
Nóbrega AC; Rodrigues B; Torres AC; Enzo A; Melo A
J Neurol Sci; 2007 Feb; 253(1-2):85-7. PubMed ID: 17229441
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
Mancini F; Zangaglia R; Cristina S; Sommaruga MG; Martignoni E; Nappi G; Pacchetti C
Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273
[TBL] [Abstract][Full Text] [Related]
11. Silent aspiration in Parkinson's disease patients with diurnal sialorrhea.
Nóbrega AC; Rodrigues B; Melo A
Clin Neurol Neurosurg; 2008 Feb; 110(2):117-9. PubMed ID: 18023964
[TBL] [Abstract][Full Text] [Related]
12. Drooling in Parkinson's Disease: Evidence of a Role for Divided Attention.
Reynolds H; Miller N; Walker R
Dysphagia; 2018 Dec; 33(6):809-817. PubMed ID: 29785679
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial.
Chinnapongse R; Gullo K; Nemeth P; Zhang Y; Griggs L
Mov Disord; 2012 Feb; 27(2):219-26. PubMed ID: 21887710
[TBL] [Abstract][Full Text] [Related]
14. Drooling, Swallowing Difficulties and Health Related Quality of Life in Parkinson's Disease Patients.
Arboleda-Montealegre GY; Cano-de-la-Cuerda R; Fernández-de-Las-Peñas C; Sanchez-Camarero C; Ortega-Santiago R
Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360429
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and relation of dementia to various factors in Parkinson's disease.
Rana AQ; Yousuf MS; Naz S; Qa'aty N
Psychiatry Clin Neurosci; 2012 Feb; 66(1):64-8. PubMed ID: 22250611
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical correlates of drooling in Parkinson disease: a study on 518 Chinese patients.
Ou R; Guo X; Wei Q; Cao B; Yang J; Song W; Shao N; Zhao B; Chen X; Shang H
Parkinsonism Relat Disord; 2015 Mar; 21(3):211-5. PubMed ID: 25537930
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
Mov Disord; 2006 May; 21(5):704-7. PubMed ID: 16440332
[TBL] [Abstract][Full Text] [Related]
18. Drooling rating scales in Parkinson's disease: A systematic review.
Nascimento D; Carmona J; Mestre T; Ferreira JJ; Guimarães I
Parkinsonism Relat Disord; 2021 Oct; 91():173-180. PubMed ID: 34583888
[TBL] [Abstract][Full Text] [Related]
19. Motor subtypes and other risk factors associated with drooling in Parkinson's disease patients.
Mao CJ; Xiong YT; Wang F; Yang YP; Yuan W; Zhu C; Chen J; Liu CF
Acta Neurol Scand; 2018 May; 137(5):509-514. PubMed ID: 29315470
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility and validity of patient-rated assessment of speech, swallowing, and saliva control in Parkinson's disease.
Kalf JG; Borm GF; de Swart BJ; Bloem BR; Zwarts MJ; Munneke M
Arch Phys Med Rehabil; 2011 Jul; 92(7):1152-8. PubMed ID: 21704797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
